McKesson reported $403.4B in revenue and $4.8B in net income for fiscal 2026.
See the full MCK financial statements: income statement, balance sheet, cash flow and ratios, each column linked to its SEC filing.
McKesson Declares Quarterly Dividend
The Board of Directors of McKesson Corporation (NYSE:MCK) has declared a regular dividend of 47 cents per share of common stock.
IRVING, Texas--(BUSINESS WIRE)--
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 47 cents per share of common stock. The dividend will be payable on January 3, 2022, to stockholders of record on December 1, 2021.
About McKesson Corporation
McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by our ICARE shared principles, our employees work every day to innovate and deliver opportunities that make our customers and partners more successful – all for the better health of patients. McKesson has been named a “Most Admired Company” in the healthcare wholesaler category by FORTUNE, a “Best Place to Work” by the Human Rights Campaign Foundation, and a top military-friendly company by Military Friendly. For more information, visit www.mckesson.com.
